Vous êtes sur la page 1sur 53

ACID RELATED DISORDERS

ADMITTING CONFERENCE AND TOPIC DISCUSSION


MENG MADDUMBA

THE PT.
GENERAL DATA

This is the case of DZG,


13/F, born on May 23 2001
BP: LMC, San Fernando City, La Union,
POR: Dontogan, Baguio City,
Student
Roman Catholic
Filipino

HISTORY
OF PRESENT ILLNESS

Admissio
n

7 DAYS
PTA pain
(+) Epigastric

after skipping meals, burning in nature


rated 5/10, localized, non-radiating
aggravated by an empty stomach, minimally relieved by
food intake

(+) Dysuria and Increase in frequency of voiding


(-) associated: N/V, Anorexia,
diarrhea, febrile episodes, chest
pains or DOB.

HISTORY
OF PRESENT ILLNESS

Admissio
n

7 DAYS
PTA
Consult
at a private
clinic
Dx: ARD + UTI
Meds Given:
CEFIXIME BID (dosage
unrecalled)
OMEPRAZOLE 20mg/tab OD

HISTORY
OF PRESENT ILLNESS

6 DAYS 2 DAYS
PTA
7 DAYS
PTA pain
(+) Epigastric
(+) Dysuria
(+) Consult
Dx: ARD + UTI
(-) associated
S/Sx

Admissio
n

(+) Dysuria and frequency of voiding decreasing


up to
two days PTA
(+) Epigastric pain, same characteristics
Decreasing pain rating from 6 to 2-3/10
Decreasing
in frequency from 3 to 1
(-) associated: N/V, Anorexia,
episodes
diarrhea, febrile episodes, chest
pains or DOB.

HISTORY
OF PRESENT ILLNESS

(+) Epigastric pain


(+) Dysuria
(+) Consult
(-) associated
S/Sx
Medications
continued

6 DAYS 2 DAYS
PTA
7 DAYS
PTA pain
(+) Epigastric
(+) Dysuria
(+) Consult
Dx: ARD + UTI
(-) associated
S/Sx

Admissio
n

HISTORY
OF PRESENT ILLNESS

(+) Epigastric pain


(+) Dysuria
(+) Consult
(-) associated
S/Sx
Medications
continued

6 DAYS 2 DAYS
PTA
7 DAYS
PTA pain
(+) Epigastric
(+) Dysuria
(+) Consult
Dx: ARD + UTI
(-) associated
S/Sx

Admissio
n

1 DAY PTA
(+) continuous epigastric pain after missing a
meal.

Burning in nature, Rated 6-7/10,


Radiating to anterior chest area; left
Aggravated by intense training and minimally relieved by
rest and
(+) medications.
Associated DOB and weakness
(-) associated: N/V, Anorexia, diarrhea,
febrile episodes, .

HISTORY
OF PRESENT ILLNESS

(-) associated
S/Sx
Medications
continued

6 DAYS 2 DAYS
PTA
7 DAYS
PTA pain
(+) Epigastric
(+) Dysuria
(+) Consult
Dx: ARD + UTI
(-) associated
S/Sx

1 DAY PTA
(+) Epigastric pain
(+) Associated
DOB and
weakness

Admissio
n

FEW HRS
PTA Pain
(+) Epigastric

Same
characteristics
Rated 8-9/10

HISTORY
FEEDING HISTORY

At present, the diet is slightly below the


patients daily calorie requirement

Based on a 2,500 kcal RENI of 13 year old female


adolescent.

HISTORY

GROWTH AND DEVELOPMENTAL

Weight and Height:

Weight= 46 kg
Height= 1.57m
BMI: 18.66 = Normal

Physical growth:
No reported delays in growth
and Development.
No observed impairments

HISTORY

GROWTH AND DEVELOPMENTAL

Psychological and Cognitive


Development
(HEADS)
HOME
good interaction with family
members
with occasional fights with
siblings.
Still respectful of
authorities and nonrebellious.
More concerned about his
looks, clothes and body
image.

HISTORY

GROWTH AND DEVELOPMENTAL

Psychological and Cognitive


Development
EDUCATION (HEADS)
More influenced by her
peer groups in school
though not rebellious
towards authority.
Verbalized having hard
time in more challenging
academic requirement.
At present the patients
developmental
milestone is at par for
age.

HISTORY

GROWTH AND DEVELOPMENTAL

Psychological and Cognitive


Development
ACTIVITIES (HEADS)
Physically Active
Member of the National
Wushu Team
Competes at
International
competition
DRUGS
No history of use or
plans of using

SUICIDE
No grave problems
that would warrant
suicidal ideologies

HISTORY
IMMUNIZATION STATUS

Claims to have complete immunization status


PAST MEDICAL

2001

2004

BETHANY
HOSPITAL
LA UNION
- Innocent Heart
Murmurs
- Anemia
D/C WELL

SLU-HSH
- Pneumonia
- Benign Febrile
Convulsions
D/C WELL

2007
SLU-HSH
- Pneumonia

D/C WELL

Childhood illness: measles, mumps, UTI, and occasional cough


and colds
Allergies: No known allergies

HISTORY
FAMILY DISEASES

Diseases in the Family:


Both parents are presently well. Patient has a
family history of HPN, Diabetes Mellitus,
Arthritis, Colon cancer, CVD, and CAD.
No reported history of other heredofamilial diseases and
other communicable diseases. No other persons residing in
their home was noted to have illness.

REVIEW
OF SYSTEMS

General: (-) weight loss, (-) fever, (-) chills, (-) sweats, (-) irritability, (+)
poor oral intake,
(+) weakness
Head and Neck: (-) trauma, (-) lesions, (-) swelling, (+) headache, (-)
pain, (-) stiffness
Respiratory: (-) productive cough, (-) pain, (+) DOB, (-) hemoptysis, (-)
cyanosis, (-) TB/PPKI
Cardiovascular: (-) edema, (-) cyanosis, (-) palpitation, (+) chest pains
(-) murmur, (-) known CHD
GIT: (+) good oral intake; (-) anorexia, (+) abdominal pain, (-)
vomiting, (-) nausea, (-) diarrhea, (-) constipation, (-) flatulence, (-)
melena, (-) hematochezia,
(-) change in bowel habits, (-) hernia, (+) use of laxatives or antacids,

PHYS.EX
PERTINENT FINDINGS

General Survey:
Awake, conscious, coherent, afebrile, not in cardiorespiratory
distress.

Vital Signs and Anthropometric


Measurements
CR= 98 bpm
Weight= 46 kg
RR= 24 cpm
Height= 1.57m
T= 36.6 C per axilla
BMI: 18.66 = Normal

No signs of Dehydration
Chest/Lungs and Heart:
SCWE (-)retractions, (-) lagging , clear breath sounds,

PHYS.EX
PERTINENT FINDINGS

Abdomen:
Flat, non-distended
(+) normoactive bowel sounds
(+) tympanitic on all four quadrants
Soft
(+) tenderness on epigastric area upon deep
palpation,
(-) masses palpated
(-) organomegaly

IMPRESSION
DIAGNOSIS OF THE PT

HISTORY (S)
Previous Dx:
Acid related
disorder
Under
gastric
medications

History of:
(+) Epig Pain (89/10)
Burning in nature
Radiating to chest
Precipitated by an
empty stomach
Aggravated by
activity
Relieved by food
intake and
medication
(-) Febrile episode

PHYS.EX (O)
Flat, non-distended
Normoactive bowel
sounds
(-) Visible Mass and
Pulsation
(-) Palpated Mass
Direct tenderness on
Epigastric area
(-) pathologic
gallbladder/
appendyceal signs

IMPRESSION
DIAGNOSIS OF THE PT

DAY10
Initial Impression: ARD
Gastroesophageal Reflux
Disease (GERD)

PLAN
DIAGNOSTICS

URINALYSIS
Unremarkable Results

PLAN
DIAGNOSTICS

CBCP
Normochromic, normocytic
RBCs
Normal: Hgb, Hct, Platelets,
WBC (neutrophilic
predominance)
*Essentially normal

PLAN
DIAGNOSTICS

Hook to D5NM 1li x 21


gtts/min computed at M%
Omeprazole 20 mg every 12
hours
Al + Mg Hydroxide (Maalox) 15
mL every after meals

DISCUSSION

'Acid-related disorders' is a term used


to describe a whole range of conditions,
where acid is entirely responsible for the
problems. Careful evaluation of the
patient's symptoms is required to establish
the basis for the
gastric
problem
Acid-related disorders: what are they? By: Colin-Jones D

Five Components of the Evaluation of


Children with Abdominal Pain
1. History
2. Physical Examination
3. Laboratory Tests
4. Imaging Studies
5. Empiric Interventions

Chronic Abdominal Pain in Childhood: Diagnosis and Management


ALAN M. LAKE, M.D., Johns Hopkins University School of Medicine, Baltimo
Maryland
Am Fam Physician.

Five Components of the Evaluation of


Children with Abdominal Pain

1. History
2.
3.
4.
5.

Physical Examination
Laboratory Tests
Imaging Studies
Empiric Interventions
Chronic Abdominal Pain in Childhood: Diagnosis and Management
ALAN M. LAKE, M.D., Johns Hopkins University School of Medicine, Baltimore,
Maryland
Am Fam Physician.

More than one third of children complain of


abdominal pain lasting two weeks or
longer. The diagnostic approach to
abdominal pain in children relies heavily
on the history provided by the parent
and child to direct a step-wise approach to
Chronic Abdominal Pain in Childhood: Diagnosis and Management
investigation.ALAN M. LAKE, M.D., Johns Hopkins University School of Medicine, Baltimore,
Maryland
Am Fam Physician.

PHYSIO
REVIEW
Two primary functional zones:
A) oxyntic gland area (80% of the organ)
B) pyloric gland area (remaining 20%)
Parietal cells (oxyntic glands) = hydrochloric acid
and intrinsic factor
Chief cells (oxyntic glands) = pepsinogen.
Neuroendocrine cells = regulate the activity of
the parietal cell.

D cells
enterochromaffin-like (ECL) cells
A-like cells
enterochromaffin (EC) cells.

PHYSIO
REVIEW
The principal stimulants for acid secretion are:
a) Histamine
major paracrine stimulator of acid secretion

b)

Gastrin

main stimulant of acid secretion during meal


stimulation

c) Acetylcholine
directly stimulates acid secretion by binding to
muscarinic (M3)
receptors

**released from postganglionic enteric neurons

PHYSIO
REVIEW
The principal stimulants for acid secretion are:
a) Histamine
major paracrine stimulator of acid secretion

b)

Gastrin

main stimulant of acid secretion during meal


stimulation

c) Acetylcholine
directly stimulates acid secretion by binding to
muscarinic (M3)
receptors

**released from postganglionic enteric neurons

Inflammation of the gastric and


duodenal mucosa is the end result of
an imbalance between mucosal
defensive and aggressive factors. The
degree of inflammation and imbalance
between defensive and aggressive factors
can then result in varying degrees
of
Pediatric gastritis and peptic ulcer disease.
Blecker U1, Mehta DI, Gold BD.
gastritis and/or mucosal ulceration.

GERD

GERD
DISCUSSION

Gastroesophageal reflux disease is the


exposure of esophageal mucosa to
a) acidic gastric contents
b) Pepsin
c) bile acids.
Can lead to: Esophageal mucosal injury:
Erosive Esophagitis

GERD
DISCUSSION

Gastroesophageal reflux disease is the


exposure of esophageal mucosa to
a) Acidic gastric contents
b) Pepsin
c) Bile acids.
Can lead to: Esophageal mucosal injury:
Erosive Esophagitis

GERD

CLINICAL PRESENTATION

DISCUSSION

Signs and symptoms (Infants Younger


Children):

Typical or atypical crying and/or irritability


Apnea and/or bradycardia
Poor appetite; weight loss or poor growth (failure to thrive)
Apparent life-threatening event
Vomiting
Wheezing, stridor
Abdominal and/or chest pain
Recurrent pneumonitis
Sore throat, hoarseness and/or laryngitis
Chronic cough
Water brash

GERD

CLINICAL PRESENTATION

DISCUSSION

Signs and symptoms (Older Children):


Signs and symptoms in older children include all
of the mentioned plus:
Heartburn and a history of vomiting
Regurgitation
Unhealthy teeth
Halitosis

GERD

DIAGNOSIS

DISCUSSION

a)History and physical


examination
b) Esophageal pH monitoring
c) Combined multiple intraluminal impedance (MII)
and pH recording
d) Endoscopy and biopsy
e) Empiric trial of acid-suppressive
Pediatric gastroesophageal
as reflux
a diagnostic
clinical practice
guidelines: joint recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
test
Nutrition (NASPGHAN) and the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN).

GERD

DIAGNOSIS

DISCUSSION

In infants and toddlers, there is no


symptom or group of symptoms that
can reliably diagnose GERD or predict
treatment response.(B)
Pediatric gastroesophageal reflux clinical practice
guidelines: joint recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN).

GERD

DIAGNOSIS

DISCUSSION

In older children and adolescents a history


and physical examination are generally
sufficient to reliably diagnose GERD and
initiate management.
Pediatric gastroesophageal reflux clinical practice
guidelines: joint recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN).

GERD

MANAGEMENT

DISCUSSION

Treatment
Parental education, guidance, and support
Lifestyle changes
Pharmacologic therapies
Surgical therapy
Pediatric gastroesophageal reflux clinical practice
guidelines: joint recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN).

GERD

MANAGEMENT

DISCUSSION

Conservative measures:
Providing small, frequent feeds thickened
with cereal
Upright positioning after feeding
Elevating the head of the bed
Prone positioning (infants >6 months)

GERD

MANAGEMENT

DISCUSSION

Older Children:
Diet that avoids tomato and citrus products,
fruit juices, peppermint, chocolate, and
caffeine-containing beverages
Smaller, more frequent feeds
Relatively lower fat diet (lipids retards gastric
emptying)
Proper eating habits
Weight loss
Avoidance of alcohol and tobacco, when
applicable

GERD

MANAGEMENT

DISCUSSION

Older Children:
Diet that avoids tomato and citrus products,
fruit juices, peppermint, chocolate, and
caffeine-containing beverages (?)
Smaller, more frequent feeds
Relatively lower fat diet (lipids retards gastric
emptying)
Proper eating habits
Weight loss
Avoidance of alcohol and tobacco, when
applicable

GERD

MANAGEMENT

DISCUSSION

In older children and adolescents, there is


no evidence to support specific dietary
restrictions to decrease symptoms of
GER. In adults, obesity and late-night eating
are associated with GER.
(A)
Pediatric gastroesophageal reflux clinical practice
guidelines: joint recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN).

GERD

MANAGEMENT

DISCUSSION

In older children and adolescents, there is


no evidence to support specific dietary
restrictions to decrease symptoms of
GER. In adults, obesity and late-night eating
are associated with GER.
(A)
Pediatric gastroesophageal reflux clinical practice
guidelines: joint recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN).

GERD

MANAGEMENT

DISCUSSION

In adolescents with GERD, left-side


sleeping positioning and elevation of the
head of the bed may decrease symptoms
and GER. (A)
Pediatric gastroesophageal reflux clinical practice
guidelines: joint recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN).

GERD

MANAGEMENT

DISCUSSION

PHARMACOLOGY
Antacids :
aluminum hydroxide, magnesium hydroxide

Histamine H2 antagonists :
nizatidine, cimetidine, ranitidine, famotidine

Proton pump inhibitors:


lansoprazole, omeprazole, esomeprazole,
dexlansoprazole, rabeprazole sodium,
pantoprazole

GERD

MANAGEMENT

DISCUSSION

Histamine-2receptor antagonists
(H2RAs) produce relief of symptoms and
mucosal healing.(A)
Proton pump inhibitors (PPIs) are
superior to H2RAs in relieving symptoms
Pediatric gastroesophageal reflux clinical practice
and healing esophagitis.(A)
guidelines: joint recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN).

GERD

MANAGEMENT

DISCUSSION

SURGICAL INTERVENTION
gastrostomy or fundoplication is required in only a
very small minority of patients with
gastroesophageal reflux
The goal of surgical antireflux procedures is to
"tighten" the region of the lower esophageal
junction and, if possible, to reduce hiatal herniation
of the stomach

GERD

MANAGEMENT

DISCUSSION

SURGICAL INTERVENTION
gastrostomy or fundoplication is required in only a
very small minority of patients with
gastroesophageal reflux
The goal of surgical antireflux procedures is to
"tighten" the region of the lower esophageal
junction and, if possible, to reduce hiatal herniation
of the stomach

GERD

MANAGEMENT

DISCUSSION

Antireflux surgery should be considered


only in children with GERD and failure of
optimized medical therapy,orlong-term
dependence on medical therapy where
compliance or patient preference preclude
ongoing use,orlife-threatening
gastroesophageal reflux clinical practice
complications.(C) Pediatric
guidelines: joint recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN).

THANK YOU FOR LISTENING


ADMITTING CONFERENCE AND TOPIC DISCUSSION
MENG MADDUMBA

Vous aimerez peut-être aussi